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Abstract
We designed a fiber-optic-based optoelectronic fluorometer to
measure emitted fluorescence from the auto-fluorescent electron carriers
NADH and FAD of the mitochondrial electron transport chain (ETC). The ratio
of NADH to FAD is called the redox ratio (RR = NADH/FAD) and is an indicator
of the oxidoreductive state of tissue. We evaluated the fluorometer by
measuring the fluorescence intensities of NADH and FAD at the surface of
isolated, perfused rat lungs. Alterations of lung mitochondrial metabolic state
were achieved by the addition of rotenone (complex I inhibitor), potassium
cyanide (KCN, complex IV inhibitor) and/or pentachlorophenol (PCP,
uncoupler) into the perfusate recirculating through the lung. Rotenone- or
KCN-containing perfusate increased RR by 21% and 30%, respectively. In
contrast, PCP-containing perfusate decreased RR by 27%. These changes are
consistent with the established effects of rotenone, KCN, and PCP on the
redox status of the ETC. Addition of blood to perfusate quenched NADH and
FAD signal, but had no effect of RR. This study demonstrates the capacity of
fluorometry to detect a change in mitochondrial redox state in isolated
perfused lungs, and suggests the potential of fluorometry for use in in vivo
experiments to extract a sensitive measure of lung tissue’s health in realtime.

Keyterms: Lung surface fluorometry, Nicotinamide Adenine Dinucleotide
(NADH), Flavin Adenine Dinucleotide (FADH2), mitochondrial redox

Introduction
The mitochondrial metabolic coenzymes NADH (Nicotinamide
Adenine Dinucleotide) and FADH2 (Flavin Adenine Dinucleotide) are the
primary electron carriers in oxidative phosphorylation. NADH and
FADH2 oxidation via the mitochondrial electron transport chain results
in the translocation of protons from mitochondrial complexes I, III and
IV across the inner mitochondrial membrane into the mitochondrial
intermembrane space. The resulting proton gradient along with
adenosine diphosphate (ADP) availability control the rate of
mitochondrial ATP synthesis, which accounts for ~85% of ATP
production in lung tissue [1]. Thus, a change in redox
status/concentration of mitochondrial NADH and/or FADH2 is an index
of a change in lung tissue mitochondrial bioenergetics, and hence an
index of mitochondrial function [2, 3].
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Optical fluorescence techniques have the potential to monitor
tissue metabolic status in real time in a non-destructive manner in
intact organs both in vivo and ex vivo [4–10]. These techniques have
been widely used to probe tissue redox state and energy homeostasis
in organs such as the heart [8], brain [10], kidney [11], liver [12],
skeletal muscle [13], cervix [14], and colon [15], but have not been
fully used in lungs [16]. The mitochondrial metabolic coenzymes NADH
and FAD (oxidized form of FADH2) are auto-fluorescent and can be
monitored using optical techniques [7]. The fluorescence signals of
these intrinsic fluorophores have been used as indicators of tissue
metabolism in injuries due to hypoxia [17], ischemia, and cell death
[4]. We have demonstrated that the ratio of these fluorophores,
(NADH/FAD), termed the mitochondrial redox ratio (RR), is a marker
of the mitochondrial redox and metabolic state of myocardial tissue in
intact hearts and in vivo [4–6, 17]. The redox ratio provides a
measure of the mitochondrial redox state that is independent of
various factors that affect the measurement of NADH and FAD
fluorescence signal, including blood volume and mitochondrial protein
concentration [18]. The objective of this study was to demonstrate the
utility of these optical fluorescence techniques to evaluate lung tissue
mitochondrial redox state (NADH/FAD) in isolated perfused rat lungs
with high sensitivity, and quantify the impact of blood on NADH and
FAD fluorescence signals and their ratio. Isolated perfused lungs are
particularly attractive to study in this regard since perfusate and/or
ventilation gas composition can be altered to modify the
oxidoreductive state of tissue mitochondria. Our results demonstrate
the ability of these techniques to detect a change in lung tissue
mitochondrial redox state in isolated perfused lungs, and set the stage
for in vivo studies.

Materials and Methods
Materials
Fatty-acid free bovine serum albumin (Standard Powder, BSA)
was purchased from Serologicals Corp. (Gaithersburg, MD). All other
reagent grade chemicals were purchased from Sigma Chemical
Company.
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Fluorometer
The fiber-optic-based fluorometer device designed for this study
has undergone several improvements and iterations over our original
design [19, 20]. The initial design included a pneumatic filter wheel
which was used both for filtering of excitation and emission
fluorescence. However, to eliminate the need for compressed air to
use the device, the second design replaced the pneumatic filter wheel
with two synchronized electric filter wheels. After further investigation,
it became apparent that the use of separate detectors for each
fluorophore would be beneficial. Therefore, the emission filter wheel
was supplanted by the combination of a dichroic mirror and static
filters. Finally, to correct for interfering factors such as hemodynamics,
a beam splitter was added to detect diffuse reflectance from the
tissue. A schematic for the iteration of the fluorometer device used in
this study is shown in Figure 1.a. Excitation light is generated from a
mercury arc lamp (Intensilight, Nikon, Tokyo, Japan), and coupled to a
liquid light guide. The light is then fed into a filter wheel (Lambda-3,
Sutter Instrument, CA), where the appropriate excitation wavelength
can be selected. On the other side of this filter wheel is one leg of a
bifurcated fiber bundle (Newport Instrument, NJ) with a distal end of
3.2 mm inner diameter. This distal tip (Figure 1.b.) is brought into
contact with the tissue under investigation to deliver the appropriate
excitation light and collect the corresponding fluorescence emission.
The emitted light, along with reflection of the excitation is then
delivered through the other leg of the bifurcated fiber bundle to the
detection optics. After the light exits the fiber bundle, it is collimated
and split using a beam splitter (UVBS14-1, Newport Instruments, CA).
Half of the light is then incident on an avalanche photodiode (PDA25K,
ThorLabs, NJ) for detection of reflected light. The other half of the light
then passes through a dichroic mirror (DMLP505R, ThorLabs, NJ) to
separate the NADH and FAD channels. In either of the channels, the
light is then filtered to select the emitted fluorescence, remove any
remaining reflection as background, and is finally incident on a
photomultiplier tube (PMT; PMM02, ThorLabs, NJ). Synchronization of
excitation and detection is achieved through the use of a custom
LabVIEW program. To optimally excite the fluorophores of interest,
NADH and FAD, using the mercury arc lamp, the excitation filters used
were centered at 370 nm (FF01-370/36, Semrock, NY) and 452 nm
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(FF01-452/45, Semrock, NY), with bandwidths of 40 nm and 50 nm,
respectively. The dichroic mirror used to separate the emission of each
fluorophore has its transition wavelength at 505 nm. Finally, the filters
used to detect the emitted fluorescence are centered at 460
(D460/40M, Chroma, VT) and 520 nm (D520/40M, Chroma, VT),
respectively, each with a bandwidth of 40 nm.

Figure 1
a) Schematic of the Fluorometer. b) Fluorescence surface measurement in an isolated
perfused rat lung.

Isolated perfused rat lung preparation
The utility of the aforementioned fluorometer for measuring lung
surface mitochondrial NADH and FAD signal was evaluated using the
isolated perfused lung preparation which has been described
previously [21]. This preparation provides a means for manipulating
lung tissue mitochondrial redox state without disrupting the multicellular environment of the lung, by adding metabolic inhibitor(s) to
the recirculating perfusate and/or altering the composition of the
ventilation gas. Adult (300–350 g, male) Sprague Dawley rats (Charles
Rivers) were anesthetized with pentobarbital sodium (40 mg/kg body
wt. i.p.), the trachea was clamped, the chest opened and heparin (0.7
IU/g body wt.) injected into the right ventricle. The pulmonary artery
and the trachea were cannulated, and the pulmonary venous outflow
was accessed via a cannula in the left atrium. The heart-lung was
removed from the chest and attached to a ventilation and perfusion
Annals of Biomedical Engineering, Vol. 41, No. 4 (April 2013): pg. 827-836. DOI. This article is © Springer and permission
has been granted for this version to appear in e-Publications@Marquette. Springer does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Springer.

5

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

system. The control perfusate contained (in mM) 4.7 KCl, 2.51 CaCl2,
1.19 MgSO4, 2.5 KH2PO4, 118 NaCl, 25 NaHCO3, 5.5 glucose, and 3%
bovine serum albumin (BSA) [22]. The perfusion system was primed
(Masterflex roller pump) with the control perfusate maintained at 37°C
and equilibrated with 15% O2, 6% CO2, balance N2 resulting in
perfusate pO2, pCO2 and pH of ~105 Torr, 40 Torr, and 7.4,
respectively. Initially, control perfusate was pumped through the lung
until it was evenly blanched and venous effluent was clear of blood.
The lung was ventilated (40 breaths/min) with end-inspiratory and
end-expiratory pressures of ~ 6 and 3 mmHg, respectively, with the
above gas mixture. The pulmonary arterial pressure was referenced to
atmospheric pressure at the level of the left atrium and monitored
continuously during the course of the experiments. The venous
effluent pressure was atmospheric pressure. This procedure and the
experimental protocols described below were approved by the
Institutional Animal Care and Use Committees of the Zablocki Veterans
Affairs Medical Center and Marquette University (Milwaukee, WI).

Experimental protocols
Fluorometer linear response
To evaluate the linearity and sensitivity of the fluorometer to a
change in NADH or FAD signal, we measured the NADH and FAD
fluorescence signals in cuvettes containing aqueous solution with
different NADH and/or FAD concentrations. The range of NADH and
FAD concentrations studied encompassed the NADH and FAD
concentrations in lung tissue [16, 23].

Lung surface fluorescence measurements
The fluorometer was used in a dark room to minimize stray-light
effects [4, 5, 24]. At the beginning of each experiment, NADH and FAD
fluorescence standards were measured to account for day-to-day
variations in light intensity. Surface fluorescence was then measured
by placing the fiber optic probe against the pleural surface of the right
lobe (Figure 1.b). For a given lung, NADH and FAD surface
fluorescence signals were first acquired under resting conditions (lung
perfused with control perfusate and ventilated with 15% O2, 6% CO2
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balance N2 ventilation gas), and then following the addition of one or
more of the following agents (rotenone, potassium cyanide, and
pentachlorophenol) to the recirculation perfusate. Rotenone (20 μM)
was used to inhibit mitochondrial complex I activity, which would be
expected to increase NADH signal by reducing the chain upstream
from complex I, and decrease FAD signal from lipoamide
dehydrogenase (LipDH) [25], which is an element of the pyruvate
dehydrogenase complex [26]. As a mitochondrial complex IV inhibitor,
potassium cyanide (KCN, 2 mM) would be expected to reduce the
chain upstream from complex IV and hence increase NADH signal and
decrease FAD signal from LipDH, succinate dehydrogenase (complex
II), and electron transfer flavoproteins (ETF) which are the main
sources of FAD signal [25]. Uncoupled mitochondrial condition was
achieved by the addition of pentachlorophenol (PCP, mitochondrial
uncoupler; 3 mM) to the recirculating perfusate and by ventilation of
the lungs with 95% O2: 5% CO2 to maximize the oxidation of the
electron transport chain. As a protonophore, PCP should oxidize the
chain and hence decrease NADH signal and increase FAD signal. For
some of the lungs, KCN was added after the initial addition of rotenone
or PCP. The above concentrations of rotenone, KCN, and PCP were
chosen to achieve maximal inhibition or uncoupling and hence
maximal changes in NADH and/or FAD signal [16, 21].
To evaluate the quenching effect of blood on the NADH and FAD
signals, surface fluorescence measurements were carried out in a
separate group of lungs first perfused with control perfusate, then
following the addition of autologous blood to the recirculating
perfusate in ~ 0.5 ml increments to achieve perfusate hematocrit (Hct)
levels of ~ 0.5%, 1.0%, 1.5%, 2%, 2.5%, 3%, 3.5%, and 4%. This
range of perfusate hematocrit was chosen based on the results of a
previous study by Chance et. al [18]. At the end of this protocol, KCN
was added to the recirculating blood-containing perfusate to evaluate
the ability of the system to detect a change in NADH, FAD, and RR =
NADH/FAD in the presence of red blood cells (4 % Hct).
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Fluorescent Signal Processing
NADH, FAD, and redox ratio (NADH/FAD)
The signal measured by the fluorometer contains a time shared
sequence of NADH and FAD pulses collected from the surface of the
lung. The trend of the data was first calculated by extracting the
maximum value of each pulse. This trend was then smoothed out
using a fourth order median filter followed by a fourth order moving
average filter. The resulting NADH and FAD signals were then
normalized by dividing each by its baseline value (signal level in the
absence of any metabolic inhibitor or uncoupler). The normalized
signals were then used to calculate the mitochondrial redox ratio, RR =
(normalized NADH)/(normalized FAD), which has a baseline value of 1.

Reflectance signal
For experiments in which blood was added to the perfusate, the
NADH and FAD reflectance signals were also measured in both
channels. The quenching effect of blood on the surface fluorescence
NADH and FAD signals was then corrected for by subtracting the
normalized reflectance signals from the normalized fluorescence
signals [27]. Thus, the following equation was used for RR in the
presence of red blood cells.

Statistical evaluation of data
Data are presented as means ± standard error (SE) unless
otherwise stated. Statistical comparisons were carried out in each
group using a two-tailed student’s t-test or one way ANOVA followed
by Tukey’s HSD (Honestly Significant Difference) post-hoc test, with p
< 0.05 as the criterion for statistical significance.
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Results
The fluorometer demonstrates a linear response to a change in
the concentration of NADH (or FAD) in the presence of FAD (or NADH)
over a wide range of NADH and FAD concentrations as shown in Figure
2.

Figure 2
Sensitivity curves of the Fluorometer to changes in a) FAD and b) NADH concentration
in an aqueous solution. All intensities are normalized to the signal level obtained at a
concentration equal to that in lung tissue. Solid lines are linear regression fits (r2 =
0.999 and 0.998 for NADH and FAD, respectively). The range of NADH and FAD
concentrations studied encompassed the NADH and FAD concentrations in lung tissue
[23].

Lung ventilation added noise to both NADH and FAD lung
surface signals. However, NADH and FAD baseline data (control
perfusate) show that this noise was attenuated using a moving
average digital filter (Figure 3). The response of both NADH and FAD
lung surface signals to lung perfusion with rotenone, KCN, or PCP
appeared within a minute of adding the chemical to the perfusate
reservoir (Figure 3). An increase in NADH fluorescence signal indicates
reduction of the electron transport chain, whereas an increase in the
FAD fluorescence signal indicates oxidation of the electron transport
chain. Lung perfusion with rotenone (complex I inhibitor) reduced the
electron transport chain upstream from complex I resulting in an
increase in NADH signal by 21.5 ± 2.5 (SE) %, with no effect on FAD
signal, and increased RR by 21.3 ± 2.7 % (Table 1). Lung perfusion
with KCN (complex IV inhibitor) reduced the electron transport chain
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resulting in a 22.0 ± 2.9 % increase in NADH, 6.8 ± 2.0 % decrease in
FAD, and as a result a 30.3 ± 2.4 % increase in RR (Table 1). Lung
perfusion with PCP, which uncoupled mitochondrial electron transport
chain from phosphorylation, decreased NADH signal by 25.4 ± 3.7 %
with no effect on FAD signal (p = 0.226), resulting in a 27.2 ± 2.9 %
decrease in RR (Table 1). The p-values for the above % changes in
NADH, FAD, and RR values are reported in Table 1.

Figure 3
Lung surface NADH (top panel), FAD (middle panel), and mitochondrial redox ratio
(bottom panel) signals for (a) baseline followed by lung perfusion with Rotenone, (b)
baseline followed by perfusion with potassium cyanide (KCN), (c) baseline followed by
lung perfusion with pentachlorophenol (PCP). For each measurement (NADH, FAD and
RR) the signal was normalized to the average signal under baseline (control perfusate)
conditions.

In the presence of rotenone, KCN resulted in a small increase
(4.0 ± 0.86 (SE) %) and decrease (−3.1 ± 0.86 %) in lung surface
NADH and FAD signals, respectively, increasing RR by 7.0 ± 0.33 % as
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compared to RR value in the presence of rotenone only (Figure 4a).
The addition of KCN to PCP-treated lungs (Figure 4b) reversed the
effect of PCP on the redox status of the electron transport chain,
increasing NADH signal by 27.2 ± 2.05 %, decreasing FAD signal by
−9.6 ± 1.1 %, and as a result leading to a 38.9 ± 0.75 % increase in
RR as compared to values in the presence of PCP only (Table 2). The
p-values for the above percentage changes in NADH, FAD, and RR are
reported in Table 2.

Figure 4
Evaluating the reversibility and additivity in lung surface mitochondrial redox ratio
(RR) signals before (baseline) and after lung perfusion with perfusate containing (a)
rotenone followed by rotenone + potassium cyanide (KCN) (b) PCP followed by PCP +
KCN. The RR values were normalized to the average value under baseline (control
perfusate) conditions.

Addition of blood to the control perfusate quenched the lung
surface NADH and FAD signals (Figure 5). Increasing perfusate
hematocrit (Hct) level from 0% (control perfusate) to 1% decreased
NADH and FAD signal by ~40% (Figure 5). Further increases in
perfusate Hct had a smaller effect on the signals, with the NADH and
FAD signals approaching a steady state value at ~4% perfusate
hematocrit. This exponential relationship between the degree of
quenching of NADH and FAD fluorescence signal and perfusate Hct
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level is consistent with Beer’s law [28]. The effect of blood on RR was
relatively small and was independent of perfusate Hct within the range
of Hct studied. This result is consistent with results by Chance et al.
[18]. The results in Figure 5 also show that subtracting the normalized
reflectance NADH or FAD signal from the corresponding normalized
fluorescence signal did not completely eliminate the quenching effect
of blood, especially that which occurred between 0% and 1% Hct.

Figure 5
Lung surface NADH, FAD and mitochondrial redox ratio (RR) signals for a normal lung
perfused with sequentially increasing hematocrit levels (0% to 4% Hct, vertical dot
lines), before (uncorrected) and after (corrected) subtracting the normalized
reflectance signals from the normalized fluorescence signals.

Discussion
The results of this study demonstrate the ability of optical
fluorescence techniques to detect a change in the redox state of the
mitochondrial electron transport chain as measured by lung surface
NADH and FAD fluorescent signals. The measured changes in NADH
and FAD surface fluorescence following lung treatment with rotenone,
KCN, or PCP are qualitatively consistent with the known effects of
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these metabolic inhibitors on the redox status of the mitochondrial
electron transport chain.
Optical fluorescence techniques have been widely used to probe
tissue redox state and energy homeostasis in organs such as the heart
and liver, but have not been fully used in lungs [16]. The lung tissue
presents a greater challenge for quantitative fluorescence studies than
metabolically active tissues such as the heart or liver. The reasons
include the low mitochondrial density of lung cells compared with
metabolically active organs such as the heart [29, 30], the lungs’ air
content and high perfusion to metabolic needs ratio, and the lungs’
high collagen content which contributes to high background
fluorescence [16]. To the best of our knowledge, the 1976 study by
Fisher et al. [16] is the only study in the literature in which lung
surface fluorometry was used to probe the redox status of lung tissue
NADH. They reported relatively small changes in the NADH signal
(Table 3) in response to lung treatment with metabolic inhibitors that
are known to oxidize or reduce the mitochondrial electron transport
chain. As shown in Table 3, the results of the present study represent
a substantial improvement in our ability to detect a change in NADH
redox status in response to lung treatment with metabolic inhibitors as
compared to what Fisher et al. [16] had reported. This increased
sensitivity is mostly due to the use of optical fibers and highly sensitive
PMTs. The fiber-optic design injects light into the tissue allowing
fluorescence emission to be more heavily weighted from the
mitochondrial containing parenchymal tissue than from the surface
connective tissue fluorescence as is the case with the lens-based optics
approach used by Fisher et al. [16].

Our assumption in this study is that changes in the
mitochondrial pool of NADH is a key contributor to the measured
changes in the NADH fluorescence signal since the metabolic inhibitors
target the mitochondrial electron transport chain [31, 32]. However,
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cytosolic NADH also contributes to the lung surface NADH signal. There
are multiple processes that determine cytosolic NADH concentration,
including NADH reduction during glycolysis, and NADH oxidation by
lactate dehydrogenase. Another important cytosolic process that alters
both cytosolic and mitochondrial NADH concentration is the malateaspartate shuttle which transfers electrons across the mitochondrial
membrane from cytosolic NADH, which is oxidized to NAD+, to
mitochondrial NAD+, which is reduced to NADH [33]. Lung treatment
with rotenone, KCN, or PCP decreases mitochondrial ATP production,
stimulates glucoses [34, 35], and hence could alter cytosolic NADH
concentration. Data in this report do not permit us to distinguish the
contribution of these sources of NADH to the signal used to calculate
RR values.
NADPH, which has the same fluorescence characteristics as
NADH, may also contribute to the lung surface signal attributed to
NADH in this study. The major cytosolic source is the pentose
pathway, which requires glucose [25, 36, 37]. Other cytosolic sources
include the malic enzyme and NADP+ dependent isocitrate
dehydrogenase [25, 36, 37]. These enzymes use citrate acid cycle
metabolites to generate NADPH, and hence do not require glucose.
Mitochondrial NADPH is generated by energy-dependent mitochondrial
nicotinamide nucleotide transhydrogenase, which catalyzes the
interconversion of NADH to NADPH. Fisher et al. [37] showed that
treatment of isolated perfused rabbit lungs with potassium cyanide, an
uncoupler, or antimycin (complex III inhibitor) decreased the rate of
the NADPH dependent mixed-function oxidation of p-nitroanisole to pnitrophenol by 50% to 77% with glucose as substrate. Thus, the
increase in lung surface NADH signal in the presence of cyanide (Table
1) cannot be attributed to an increase in the NADPH signal since
cyanide decreased the rate of the NADPH-dependent mixed-function
oxidation of p-nitroanisole to p-nitrophenol [37]. On the other hand,
the decrease in measured lung surface NADH signal in the presence of
the uncoupler (Table 1) could be in part due to a decrease in NADPH
since lung treatment with the uncoupler decreased the rate of the
NADPH dependent reaction. However, the fact that KCN and PCP had
opposite effect on the lung surface NADH signal (Table 1), but the
same effect on the rate of the NADPH-dependent reaction may suggest
that NADPH is not contributing much to the measured NADH signal.
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Unlike the NADH signal which has cytosolic and mitochondrial
components, the FAD signal derives only from the mitochondria [38].
To the best of our knowledge, this study is the first to measure lung
surface FAD fluorescence. Compared to NADH, the change in the FAD
signal in response to lung treatment with the various metabolic
inhibitors was relatively small (Table 1). One reason could be due to
the lower lung tissue concentration of FAD as compared to NADH. In
fact, the FAD baseline signal is small relative to the NADH signal as
evidenced by the difference in signal amplification for the NADH and
FAD channels (103 for NADH compared to ~6 × 105 for FAD).
Sources of redox-sensitive flavoprotein (FAD) include succinate
dehydrogenase (complex II), lipoamide dehydrogenase (LipDH), and
electron transfer flavoprotein (ETF) [39, 40]. Treatment with rotenone
(complex I inhibitor), which raises mitochondrial NADH/NAD+, should
decrease LipDH flavoprotein fluorescence signal [25]. In the present
study, rotenone had no effect on FAD signal (Table 1), suggesting that
lung mitochondrial LipDH does not contribute much to the measured
lung surface flavoprotein signal.
The contribution of ETF, a fatty-acid oxidizing flavoprotein, to
the measured flavoprotein signal can be evaluated by lung treatment
with potassium cyanide (complex IV inhibitor), which reduces ETF, and
complex II flavoprotein signal [25]. Thus, the cyanide-dependent
decrease in FAD signal measured in the present study (Table 1) could
be due to ETF and/or complex II flavoprotein signal. For lung tissue,
glucose is the major oxidizable substrate under normal physiological
conditions [37]. Since glucose was the only oxidizable substrate in our
perfusate, change in FAD signals (Table 1) in the presence of cyanide
should be attributed to complex II flavoprotein rather than ETF
flavoprotein.
The contributions of complex II, LipDH, and ETF to the
measured lung surface flavoprotein signal in the present study are
different from those reported by Kunz and Kunz [39]. Whether this
difference in the contributions of these flavoprotein enzymes is
attributable to a difference between intact lungs and isolated
mitochondria, tissue differences [40], or other factors, is not known.
Finally, lung treatment with PCP had no effect on the FAD surface
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fluorescence signal (Table 2). This could be because most of the
flavoproteins (FAD + FADH2) are in the oxidized (FAD) form.
The measured changes in NADH and FAD fluorescence signals in
response to the treatments in the present study are qualitatively and
quantitatively similar to those obtained from rat hippocampal slices
[41]. Gerich et al. showed that treatment with rotenone (20 μM)
increased NADH signal by ~10% with no effect on FAD. Potassium
cyanide (100 μM or 1 mM) increased NADH by ~20% and decreased
FAD signal by ~9%. Treatment with the uncoupler carbonyl cyanide 4(trifluoromethoxy) phenylhydrazone (FCCP, 1 μM) decreased NADH by
~12% with no effect on FAD. Using isolated rat ventricular trabeculae,
Brandes and Bers [33] demonstrated using fluorescence spectroscopy
that treatment with KCN increased NADH/NAD+ by 31%, whereas
treatment with the uncoupler FCCP decreased the ratio by 49%. These
results are again consistent with the results from the present study
(Table 1).
Since in vivo estimates of RR are unavoidably acquired in the
presence of blood, we determined the effect of blood in perfusate on
NADH and FAD lung surface fluorescence signal, and on RR. The
results of the study show an exponential relationship of the quenching
effect of red blood cells on NADH and FAD fluorescence signals,
consistent with Beer’s law [28]. However, the effect of blood on RR is
relatively small and appears to be independent of blood hematocrit
level. Although the range of Hct studied (0–4%) is much lower than
rat blood Hct (44%) [29], the plateau seen in the results at 4% Hct
(Figure 5) indicates that higher perfusate Hct will have a minimal
additional quenching effect on the NADH and FAD fluorescence signals.
These results are consistent with those from a study by Chance et al.
in which they showed that perfusion of isolated organs (e.g., liver)
with perfusate containing blood (0–4% Hct) decreased NADH and FAD
signals but did not change the redox ratio [18]. Thus, we expect that
the presence of blood in perfusate will have no significant effect on the
percentage changes in RR (Tables 1 and and2).2). For instance, Figure
6 shows that potassium cyanide increased RR by ~26% in a lung
perfused with blood-containing perfusate (4% Hct). This increase in RR
is within the 22.0 ± 2.9 % (SE) range measured in lungs perfused with
blood-free perfusate (Table 1).

Annals of Biomedical Engineering, Vol. 41, No. 4 (April 2013): pg. 827-836. DOI. This article is © Springer and permission
has been granted for this version to appear in e-Publications@Marquette. Springer does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Springer.

16

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 6
Evaluating the effect of lung perfusion with KCN on surface mitochondrial redox ratio
(RR) in the presence of blood (4% Hct = hematocrit).

The lung surface optical imaging data measured in this study
does not provide information about the specific types of lung cells
contributing to the measured NADH and FAD signals, although
endothelial cells would be expected to contribute significantly because
of their relatively large surface area and fraction of total lung cells
[42]. Although determining the contributions of specific lung cell types
to the measured signal is potentially important, the global
oxidoreductive state of the lung tissue is a highly valuable piece of
information irrespective of the individual cell types contributing to the
redox ratio. Another limitation of optical surface fluorescence imaging
is that it may not detect deeper than 500 μm, with an initial diameter
of 3.2 mm, for a volume of ~4 mm3. However, this resolution is more
than sufficient for determining the RR of parenchymal tissue which has
a thickness (air to plasma) of 1.6 μm [42]. That said, central lung
lesions without pleural extension would not be expected to be detected
by surface fluorescence measurements such as those used in the
present study.
In conclusion, the results of this study demonstrate the utility of
optical fluorometry to detect a change in the redox status of lung
mitochondrial coenzymes NADH and FAD in isolated perfused lungs.
While optical determination of RR in tissues such as brain and
myocardium is accepted [4, 43], the applicability of these
methodologies in examination of the redox state in lungs, where the
density of mitochondria is much lower, has not been established. Using
low temperature fluorescence imaging, we have demonstrated that rat
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exposure to hyperoxia (85% oxygen for 7 days) decreased the NADH
signal and increased the FAD signal, resulting in an average decrease
in RR of 23% [44]. The potential clinical importance of real time
optical imaging of lungs in patients with critical illness, including
patients on high O2, or patients with ischemia-reperfusion lung injury
secondary to lung transplant, chest contusions, is great. Reliable
fluorescence determination of RR could be adopted in the same fashion
that near-infrared spectroscopy (NIRS) is gaining favor as a
noninvasive measure of tissue oxygenation in critically injured patients
[45]. While NIRS is an indirect measure of tissue oxygenation, NADH
and FAD data provide information regarding tissue redox and
mitochondrial bioenergetics, a truer and more sensitive early measure
of organ function. Our studies support the capacity of fluorescence
imaging to detect a change in mitochondrial redox state in isolated
perfused lungs, and set the stage for in vivo studies.
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